Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023: Articles

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer ^A* , Arief A. Suriawinata ^B , Shaofeng Yan ^B , Darcy A. Kerr ^B , Muhammad Z. Afzal ^A , Keisuke Shirai ^A

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

View HTML version

Figure 8. Case 3: (A) PET/CT obtained on October 29, 2020, showing a hypermetabolic mass associated with the small bowel in the left side of the abdomen is consistent with metastatic melanoma. (B) PET/CT obtained on May 27, 2021, status post-surgical resection of small bowel without evidence of local recurrence.

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy